Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense

    U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) – Directory

    • Go back to directory.
    No Photo Available

    U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)

    U.S. Army Medical Research Institute of Chemical Defense (USAMRICD)U.S. Army
    Work 3100 Ricketts Point Road Aberdeen Proving Ground MD 21010-5400 work Work Phone: 410-436-3276work Website: USAMRICD

    Biography

    The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) is the DoD’s lead laboratory for the medical chemical defense research and medical management of chemical casualties.

    USAMRICD researches toxin mechanisms of action, molecular structures, and pharmaceutical interventions. Research using protein biomarkers and enzymatic interdiction is regularly conducted as they examine the effects of all types of chemical agents and work to develop countermeasures.

    Core competencies available include biochemistry, molecular biology, animal model development and testing, microbiology, aerobiology, virology, genomics, proteomics, toxicology, veterinary medicine, human medicine, physiology, pharmacology, cell biology, immunology, and a full range of chemical and biological analytical technologies.

    USAMRICD also trains and educates numerous medical personnel in the medical management of chemical casualties.

    The Institute’s growing national and international customer base includes other government agencies, academia, pharmaceutical companies and commercial enterprises. To fulfill this expanding mission, the USAMRICD has established an Office of Consultative Services (OCS) which offers fee-based consultations.

    Countermeasures developed by USAMRICD include: TestMate Cholinesterase Kit, Nerve Agent Antidote Kit, M291 Decontaminating Kit, Pyridostigmine, Convulsant Antidote Nerve Agent, Multichambered Autoinjector, and SERPACWA.

    USAMRICD is organized under the U.S. Army Medical Research and Materiel Command (USAMRMC), with approximatley 300 employees, including researchers and support personnel.

    Notes

    Editor’s Picks: Articles and resources related to USAMRICD. Links may lead to external sites.

    APG Advanced Planning Briefing to Industry (Apr 2019)

    USAMRICD Enterprise Safety Application Management System (Jun 2015)

    Patrick McNutt Talks Chemical Weapons (Apr 2015)

    Botulinum Neurotoxin Countermeasure Discovery (Oct 2014)

    Improved Treatment for Toxic Nerve Agent (Oct 2014)

    Development of Bioscavengers for U.S. Army (Sep 2014)

    USAMRICD Leadership Changes Hands (Aug 2014)

    USAMRICD Hosts Chemical Defense Bioscience Review (Jun 2014)

    Army Seeks Farsi-English Translation of Iraqi Chemical Warfare Book (May 2014)

    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy